Is BIOMERICA INC (BMRA) Halal?
Shariah Screening — 5 Standards
Based on financial data from May 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 7.9% / 30% | 41.4% / 30% | 12.6% / 30% | 3.11% / 5% | ✗ NOT HALAL |
| DJIM | 7.9% / 33% | 41.4% / 33% | 12.6% / 33% | 3.11% / 5% | ✗ NOT HALAL |
| MSCI | 7.7% / 33% | 40.4% / 33% | 12.3% / 33% | 3.11% / 5% | ✗ NOT HALAL |
| S&P | 7.9% / 33% | 41.4% / 33% | 12.6% / 33% | 3.11% / 5% | ✗ NOT HALAL |
| FTSE | 7.7% / 33% | 40.4% / 33% | 12.3% / 50% | 3.11% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 5.6% | |
| Operating Margin | -113.5% | |
| Net Margin | -90.3% | |
| Return on Equity (ROE) | -84.3% | |
| Return on Assets (ROA) | -49.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$4M |
| Free Cash Flow | -$4M |
| Total Debt | $458,000 |
| Debt-to-Equity | 6.4 |
| Current Ratio | 3.2 |
| Total Assets | $6M |
Price & Trading
| Last Close | $2.11 |
| 50-Day MA | $2.22 |
| 200-Day MA | $2.73 |
| Avg Volume | 24K |
| Beta | 0.2 |
|
52-Week Range
$1.87
| |
About BIOMERICA INC (BMRA)
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BIOMERICA INC (BMRA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BIOMERICA INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BIOMERICA INC's debt ratio?
BIOMERICA INC's debt ratio is 7.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 7.7%.
What are BIOMERICA INC's key financial metrics?
BIOMERICA INC has a market capitalization of $6M, and revenue of $5M. The company maintains a gross margin of 5.6% and a net margin of -90.3%. Return on equity stands at -84.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.